SCHEMBL2706567

SCHEMBL2706567

[C-]#[N+]c1ccc(O)c(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.43
TRPA1 O75762 2/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
LCK P06239 1/20 0.39
ALOX5 P09917 3/20 0.37
ALOX15 P16050 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PTGS2 P35354 2/20 0.36
POLB P06746 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
IGF1R P08069 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA12 O43570 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12446575 0.78 ESR1 (0.38) CA6KDM4EHSD17B10CA9CA14
SCHEMBL13053993 0.78 HSD17B10 (0.50) CA1CA2ALDH1A1HPGDHSD17B10
SCHEMBL3438830 0.78 ALOX15 (0.50) ALOX15HPGDGAASNCA
SCHEMBL9607652 0.78 HSD17B10 (0.50) CA1CA2ALOX15PTGS2ALDH1A1
SCHEMBL13406915 0.78 ALOX15 (0.50) ALOX15KDM4EPOLBL3MBTL1ALDH1A1
SCHEMBL12704789 0.78 ALDH1A1 (0.46) CA1CA2ALOX15KDM4EPOLB
SCHEMBL14609269 0.74 APP (0.43) APPTRPA1CA1CA2CA4
SCHEMBL10019233 0.73 TUBB1 (0.47) APPCA1CA2ALOX5ALOX15
SCHEMBL13040392 0.73 KDM4E (0.33) KDM4EL3MBTL1ALDH1A1TDP1MAPT
SCHEMBL12024944 0.73 MAOB (0.55) TRPA1CA1CA2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170306079-A1 PHOSPHONIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION CONTAINING SAME, SEMICONDUCTOR DEVICE MANUFACTURED USING SAME SAMSUNG SDI CO., LTD. (KR) 2017-10-26 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-8426107-B2 Positive-type photosensitive composition TOKYO OHKA KOGYO CO., LTD. (JP) 2013-04-23 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-20110064913-A1 POSITIVE-TYPE PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD (JP) 2011-03-17 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122918-A1 ANTIBACTERIAL AGENTS ALK, ROS1, ARG1 APP 4005/4885TRPA1 3537/4885CA1 4185/4885
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 APP 3789/4885TRPA1 3164/4885CA1 3391/4885
US-20150191420-A1 ANTIBACTERIAL AGENTS ALK, ARG1, ROS1 APP 4058/4885TRPA1 3460/4885CA1 4259/4885
US-20170306079-A1 PHOSPHONIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION CONTAINING SAME, SEMICONDUCTOR DEVICE MANUFACTURED USING SAME PHOSPHO1, ASH2L, RER1 APP 2198/4885TRPA1 2204/4885CA1 1425/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 APP 3789/4885TRPA1 3164/4885CA1 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.